MarketPeel
Insider Trading Intelligence
Pricing
…
JI

Jula Inrig

TVTX
CHIEF MEDICAL OFFICER · TRAVERE THERAPEUTICS, INC. · CIK 0001902368
FILING MIX · LIFETIME40%/60%
BUYS
19
SELLS
29
TOTAL VALUE
$3.31M
COMPANIES
1
ACTIVE SINCE
Jan 2022
HOLDINGS NOW
112,770
AVG SELL PX
$34.86
TRADE KIND
SHOWING 48 / 48
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
20 backtested trades · 8 horizons · 32 pending
Forward-return performance of every backtestable P/S trade by Jula Inrig, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d20+65.00%-1.33%+1.01%-2.35%-2.98%—
14d20+55.00%-3.07%+0.88%-3.85%-3.55%—
30d20+65.00%-4.31%+1.50%-5.80%-7.72%—
60d20(1 pending)+57.89%-5.35%-0.45%-4.90%-2.42%—
90d20(2 pending)+50.00%+3.57%+1.14%+2.43%-3.51%—
180d20(6 pending)+64.29%+8.32%+9.82%-1.50%-26.26%—
1y20(8 pending)+16.67%+81.96%+20.38%+61.58%+76.98%—
2y20(15 pending)+40.00%+182.49%+51.86%+130.63%+217.82%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TVTX · 112,770 shares · as of Jun 22, 2026
032,86865,73798,605131,47320222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 19 buys / 29 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TVTX
TRAVERE THERAPEUTICS, INC.
SALEGRANT
Gift
468——112,770Jun 22, 2026Jun 22, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
311$43.95$13.7K113,238May 6, 2026May 6, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,174$46.65$101.4K113,549May 5, 2026May 6, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
CHIEF MEDICAL OFFICER
4,250——115,723May 4, 2026May 6, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
CHIEF MEDICAL OFFICER
4,250——4,250May 4, 2026May 6, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,500——8,500May 4, 2026May 6, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
CHIEF MEDICAL OFFICER
20,000——34,500May 4, 2026May 6, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
20,000$45.00$900.0K111,473May 4, 2026May 6, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
CHIEF MEDICAL OFFICER
20,000$22.40$448.0K131,473May 4, 2026May 6, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,018$42.61$43.4K111,473Apr 15, 2026Apr 15, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,215$41.93$302.5K112,491Apr 14, 2026Apr 15, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,000——119,706Apr 13, 2026Apr 15, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
232$32.85$7.6K105,706Feb 4, 2026Feb 4, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,547$32.11$49.7K105,938Feb 4, 2026Feb 4, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
CHIEF MEDICAL OFFICER
6,956$32.12$223.4K107,485Feb 3, 2026Feb 3, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,000——75,000Jan 31, 2026Feb 3, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,130——114,441Jan 31, 2026Feb 3, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
445$37.75$16.8K86,311Jan 6, 2026Jan 7, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,031$40.18$81.6K86,756Jan 5, 2026Jan 7, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
CHIEF MEDICAL OFFICER
15,000——76,000Dec 24, 2025Dec 29, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
15,000$42.00$630.0K88,787Dec 24, 2025Dec 29, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
CHIEF MEDICAL OFFICER
15,000$8.93$133.9K103,787Dec 24, 2025Dec 29, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
815$14.65$11.9K88,787Jul 1, 2025Jul 2, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
CHIEF MEDICAL OFFICER
2,568$23.53$60.4K89,602Feb 12, 2025Feb 12, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
CHIEF MEDICAL OFFICER
8,000——92,170Feb 10, 2025Feb 12, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
CHIEF MEDICAL OFFICER
8,000——0Feb 10, 2025Feb 12, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,066$20.11$21.4K84,170Feb 4, 2025Feb 4, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,207$20.12$84.6K85,236Feb 3, 2025Feb 4, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,000——89,443Jan 31, 2025Feb 4, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000——100,000Jan 31, 2025Feb 4, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
440$18.76$8.3K59,443Jan 6, 2025Jan 6, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,066$19.10$39.5K59,883Jan 3, 2025Jan 6, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
684$12.98$8.9K61,949Sep 10, 2024Sep 10, 2024 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
CHIEF MEDICAL OFFICER
2,191$11.52$25.2K62,633Sep 9, 2024Sep 9, 2024 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,750——64,824Sep 5, 2024Sep 9, 2024 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
CHIEF MEDICAL OFFICER
2,174$8.53$18.5K58,074Feb 1, 2024Feb 2, 2024 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
91,000——91,000Jan 31, 2024Feb 2, 2024 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,000——60,248Jan 31, 2024Feb 2, 2024 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Medical Officer
440$9.17$4.0K35,248Jan 4, 2024Jan 4, 2024 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Medical Officer
2,069$9.48$19.6K35,688Jan 3, 2024Jan 4, 2024 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
54,500——54,500Jan 31, 2023Feb 2, 2023 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,750——6,750Jan 31, 2023Feb 2, 2023 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,250——37,757Jan 31, 2023Feb 2, 2023 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Medical Officer
442$20.75$9.2K17,507Jan 5, 2023Jan 6, 2023 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Medical Officer
2,051$20.75$42.6K17,949Jan 4, 2023Jan 6, 2023 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,000——8,000Jan 31, 2022Feb 2, 2022 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,000——20,000Jan 1, 2022Jan 4, 2022 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,000——80,000Jan 1, 2022Jan 4, 2022 ↗View →
Other insiders · TVTX
Loading peer insiders…
About this filer
CIK 0001902368
ROLE
CHIEF MEDICAL OFFICER
PRIMARY
TVTX
COMPANIES
1
ACTIVE SINCE
Jan 2022
MARKETPEEL · /INSIDER/0001902368DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback